UK

Brexit and beyond: the challenges ahead for pharma
Brexit and beyond: the challenges ahead for pharma
Pharmaforum
Brexit
UK
Europe
Flag link:
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
Fierce Biotech
EMA
Europe
Brexit
UK
Amsterdam
Flag link:
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
NICE
UK
Amgen
Novartis
migraines
Aimovig
Flag link:
Pharma companies warned over ‘no deal’ Brexit disruption
Pharma companies warned over ‘no deal’ Brexit disruption
Pharmaforum
UK
Brexit
Flag link:
The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
The Great Pharma Brexit? An Endpoints News snap poll finds most life sciences insiders predicting a debacle for the industry
Endpoints
pharma industry
UK
Europe
Brexit
Flag link:
Survey Indicates Healthcare Professionals Have a Dim View of Post-Brexit Britain
Survey Indicates Healthcare Professionals Have a Dim View of Post-Brexit Britain
BioSpace
UK
Brexit
Flag link:
British genetic database expects $320 million investment
British genetic database expects $320 million investment
San Francisco Chronicle
genetics
UK
genetic database
UK Biobank
Flag link:
Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London
Novartis HQ is pulling up its roots in the UK and moving to a new biotech campus in London
Endpoints
Novartis
UK
Flag link:
Pharma hopes for best, fears the worst, as Brexit vote nears
Pharma hopes for best, fears the worst, as Brexit vote nears
Pharmaforum
Brexit
UK
Europe
pharma industry
Flag link:
What a draft Brexit agreement means for the medical device industry
What a draft Brexit agreement means for the medical device industry
Emergo
devices
UK
Europe
Brexit
Flag link:
While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal
While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal
Endpoints
Brexit
UK
pharma industry
NHS
ABPI
Flag link:
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Fierce Pharma
Pfizer
patents
UK
Lyrica
Flag link:
Biopharma may have to wait for Brexit details
Biopharma may have to wait for Brexit details
BioCentury
Brexit
Europe
UK
Flag link:
Half of Clinical Trials Fail to Publish Results, UK Report Finds
Half of Clinical Trials Fail to Publish Results, UK Report Finds
RAPS.org
clinical trials
UK
Europe
transparency
Flag link:
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
CP Wire
supply chain
UK
quality
Flag link:
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
supply chain
UK
quality
Flag link:
What does Brexit mean for clinical research?
What does Brexit mean for clinical research?
Mass Device
Brexit
UK
clinical trials
Flag link:
What “no-deal” Brexit means for medical devices
What “no-deal” Brexit means for medical devices
Emergo
UK
Europe
Brexit
devices
Flag link:
AZ to continue with investment freeze following ‘no deal’ Brexit
AZ to continue with investment freeze following ‘no deal’ Brexit
Pharmaforum
AstraZeneca
drug manufacturing
Brexit
UK
Flag link:
UK clinical trials fall as Brexit clouds drug approval process
UK clinical trials fall as Brexit clouds drug approval process
Reuters
UK
Brexit
clinical trials
Flag link:

Pages